## Publications

From 2012 through early 2019 I was a part-time consultant to R Street Institute as a Senior Fellow for Tobacco Harm Reduction, I generated about 50 policy papers and presentations. These are shown on the website page titled “R Street Policy Papers and Presentations.” During the period 2007 to 2012, prior to my affiliation with R Street, I generated several tobacco harm reduction related policy papers on behalf of the American Association of Public Health Physicians (AAPHP). A listing of selected R Street papers and the AAPHP papers are presented at the end of this web page document.

Nitzkin, JL: E-cigarette Tipping Points Revisited, with Historical Perspective. EC Pharmacology and Toxicology 2020 8:10; 1-7 https://www.ecronicon.com/ecpt/pdf/ECPT-08-00529.pdf

Nitzkin, JL: E-Cig Tipping Points vs. FDA Deeming Regulations. Journal of Addiction Research & Therapy. 2017 8:1 https://doi.org/10.4172/2155-6105.1000304

Nitzkin JL. What Drives Tobacco Policy? Nicotine & Tobacco Research. 2016 April 20. http://ntr.oxfordjournals.org/cgi/reprint/ntw104?ijkey=iflKpog6Q2x9V5z&keytype=ref doi: 10.1093/ntr/ntw104

Nitzkin, JL; Farsalinos, K; Siegel, M: More on Hidden Formaldehyde in E-Cigarette Aerosols. (a letter to the editor) N Engl J Med 2015. 372: 1575 April 16, 2015. DOI: 10 1056/NEJMc1502242 http://www.nejm.org/doi/pdf/10.1056/NEJMc1502242

Nitzkin, JL: E-Cigarettes: A Life-Saving Technology or a Way for Tobacco Companies to Re-Normalize Smoking in American Society? FDLI’s Food and Drug Policy Forum Volume 4, Issue 6, June 30, 2014. Available for a fee on the Food and Drug Law Institute (FDLI} web site at https://portal.fdli.org/LogIn/login.aspx?ReturnUrl=%2fPurchase%2fProductDetail.aspx%3fProduct\_code%3d36c5c . Or, free of charge, de0-5f01-e411-b0e2-0050569c00a7&Product\_code=36c5cde0-5f01-e411-b0e2-0050569c00a7 from the R Street web site (with authorization from FDLI for such posting) at http://www.rstreet.org/wp- content/uploads/2014/07/20140630FDLI-EcigForum.pdf

Nitzkin, JL: The Case in Favor of E-Cigarettes for Tobacco Harm Reduction. International Journal of Environmental Research and Public Health 2014. Published on Line 20 June 11: 6459-6471. Doi: 10.3390/ijerph110606459

Nitzkin, JL: Letter to Editor: Response to Stepanov et al. In response to Stepanov I, Knezevich A, Zhang L, Watson C, Hatsukami D, Hecht S. Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: Three decades of remarkable neglect by the tobacco industry. Tob. Control 2011 Carcinogenic tobacco-specific N- doi: 10.1136/tc.2010.042192. JLN response submitted online June 1, 2011; JLN response Published on-line July 13, 2011 http://tobaccocontrol.bmj.com/content/early/2011/05/20/tc.2010.042192/reply

Nitzkin, JL: Letter to Editor: ENDS (E-cigarettes): No such research needed. In response to Etter et al: Electronic nicotine delivery systems: a research agenda published on line first March 17, 2011, in Tobacco Control as doi: 10.1136/tc.2010.042168. JLN letter submitted April 21, 2011. JLN response Published on-line July 13, 2011. http://tobaccocontrol.bmj.com/content/20/3/243/reply Nitzkin, JL: Letter to Editor: Response to Yatsuya – RE: Risk of Incident Cardiovascular Disease Among Users of Smokeless Tobacco in the Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology. DOI: 10.1093/aje/kwq511 published on line 8 February 2011. Free Access Links: Full Texthttp://aje.oxfordjournals.org/cgi/content/full/kwq511? ijkey=2HpHGkzxOwurbbM&keytype=ref Full Text PDF: http://aje.oxfordjournals.org/cgi/reprint/kwq511?ijkey=2HpHGkzxOwurbbM&keytype=ref RE: "RISK OF INCIDENT CARDIOVASCULAR DISEASE AMONG USERS OF Full Citation: SMOKELESS TOBACCO IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY" Joel L. Nitzkin American Journal of Epidemiology 2011; doi: 10.1093/aje/kwq511